search
Penn Medicine
Trends
- 1OpenEvidence partners with Anthropic and Penn Medicine for AI expansion▼OpenEvidence partners with Anthropic, Penn Medicine to expand physician access to AI across Africa and Asia
OpenEvidence has announced a partnership with Anthropic and Penn Medicine to expand physician access to its AI-powered clinical decision support tools across Africa and Asia. The collaboration aims to bring AI assistance to doctors in regions with limited medical resources, marking a notable step in extending US-developed health AI to global markets.
- 2
Medetomidine, a potent sedative used mainly in veterinary and hospital settings, is increasingly appearing in the illicit drug supply, with clinicians reporting severe, hard-to-treat withdrawal symptoms in patients. Reports from health systems, including Penn Medicine, highlight growing concern that the drug is being mixed with opioids like fentanyl, complicating overdose response and addiction treatment.
- 3Penn Medicine plans new surgery centers in Delaware▼Penn Medicine expands Delaware push with planned surgery centers
Penn Medicine is expanding its presence in Delaware with plans to open new surgery centers. The announcement, reported by the Delaware Business Times, signals the health system's continued push into the state's healthcare market, adding outpatient surgical capacity for Delaware residents who often travel to Philadelphia for care.